Navigating the unique challenges of different therapeutic areas demands clinical development expertise and understanding.
Whether it’s intricacies of patient populations, specificity of endpoints, assessments, or the rigorous requirements of study design, anything less than a profound grasp of these elements will derail your objectives.
IDDI is your ideal biostatistical and clinical data partner, offering a solid foundation in the clinical development process and breadth of therapeutic area expertise.
Therapeutic & Specialty Areas
With IDDI, drug development is powered by exceptional scientific knowledge into cancer research, ophthalmology, CNS, and rare diseases combined with unmatched data quality acumen.
862
Oncology Trials
17 4
Ophthalmology Trials
183
Rare Disease Trials
6 2
CNS Trials
60
Cardiology Trials
48
Infectious Diseases Trials
IDDI’s Legacy of Excellence and Innovation
IDDI’s profound therapeutic experience is drawn from our involvement in 1,400+ clinical trials involving drugs, diagnostics, and medical devices, as well as a track record of assisting clients in achieving FDA/EMA approvals.
IDDI’s drug development authority is underpinned by a prolific portfolio of expert publications across esteemed medical and statistical journals and a prominent presence at leading meetings and congresses (details available upon request).
